Close

COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

Go back to COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
(NASDAQ: CMPS) Delayed: 8.10 -0.15 (1.82%)
Previous Close $8.25    52 Week High
Open $8.30    52 Week Low
Day High $8.38    P/E N/A 
Day Low $7.89    EPS
Volume 887,823       

(NASDAQ: CMPS) Delayed: 8.10 -0.15 (1.82%)
Previous Close $8.25    52 Week High
Open $8.30    52 Week Low
Day High $8.38    P/E N/A 
Day Low $7.89    EPS
Volume 887,823